Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CVS Health Corp (NYSE: CVS) is capping purchases of rapid, over-the-counter COVID-19 tests, with a maximum of six packages available online and four in its pharmacies. The limits apply to Abbott Laboratories' (NYSE: ABT) BinaxNOW along with a test from Ellume, according to an email from a CVS spokesperson, Bloomberg reported.

See Why CVS Is Limiting Purchase Of OTC COVID-19 Tests

CVS Health trades for around 10x 2022 earnings estimates and even less when valued against free cash flow, but Wall Street is ignoring it in favor of high-flying tech names. CVS is using earnings to pay down debt, but soon should be able to put through a dividend hike and buyback program.

Can CVS Stock Reach $100? Pounding The Table On My Top 2021 Pick

Cummins

Insight Enterprises

2Q21 earnings reveal these three Long Ideas continue to have strong upside potential.

Insight Enterprises, Cummins, And CVS Health Corp Will Keep Creating Shareholder Value After 2Q21

WOONSOCKET, R.I., Aug. 23, 2021 /PRNewswire/ -- CVS Health Corporation ("CVS Health", NYSE: CVS) announced today the Reference Yield and Total Consideration (each as summarized in the table below) to be paid in connection with the previously announced cash tender offer (the "Tender Offer") for up to $2,049,919,000 principal amount (the "Maximum Amount"), of its 4.300% Senior Notes due 2028 (the "Notes").

CVS Health Corporation Announces Pricing of Tender Offer

WOONSOCKET, R.I., Aug. 23, 2021 /PRNewswire/ -- CVS Health Corporation ("CVS Health", NYSE: CVS) announced today the early results of the previously announced cash tender offer (the "Tender Offer") and that it is amending the Tender Offer by increasing the aggregate principal amount to $2,049,919,000 (as increased and amended, the "Maximum Amount") from $2,000,000,000, of its 4.300% Senior Notes due 2028 (the "Notes").

CVS Health Corporation Announces Early Results and Upsize of Previously Announced Cash Tender Offer to an Aggregate Principal Amount of $2,049,919,000 from $2,000,000,000

WOONSOCKET, R.I., Aug. 18, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) is reminding Americans that as the country continues to deal with the impact of the COVID-19 pandemic it is more important than ever to stay current with vaccinations and other routine health care needs.

Flu Shots Now Available at CVS Pharmacy® and MinuteClinic®

CVS Health Corporation represents an investment with a high degree of uncertainty. CVS just closed 2020 on a disappointing note and is likely to continue to be pressured on multiple fronts in the near future.

CVS Health Corporation - Good Setup For Long Call Option Play

WOONSOCKET, R.I., Aug. 10, 2021 /PRNewswire/ -- Aetna, a CVS Health company (NYSE: CVS), announced an innovative health care solution, Aetna Virtual Primary Care, that reimagines the primary care experience and makes it easier for people to get the health services they need, anytime, anywhere.

CVS Health launches first nationwide virtual primary care solution

CVS Health recently reported its Q2 results, which were better than Trefis' as well as the street estimates. The company reported sales of $72.6 billion, up 11% y-o-y, and it was comfortably above our forecast of 70.3 billion.

Should You Buy CVS Health Stock At Around $80 Levels?

WOONSOCKET, R.I., Aug. 9, 2021 /PRNewswire/ -- CVS Health Corporation ("CVS Health") (NYSE: CVS) announced today that it has commenced a cash tender offer (the "Tender Offer") for up to $2,000,000,000 aggregate principal amount, as may be increased or decreased by CVS Health (the "Maximum Amount"), of its 4.300% Senior Notes due 2028 (the "Notes").

CVS Health Corporation Announces Cash Tender Offer for its 4.300% Senior Notes due 2028

The shares of CVS Health Corp (NYSE: CVS) received a price target increase from $95 to $101 from Deutsche Bank. These are the details.

CVS Stock Price: $101 Target From Deutsche Bank

Johnson & Johnson

Drugstore chain CVS Health Corporation (NYSE: CVS) is no longer offering Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccine in many of its retail locations, the company told CNBC on Wednesday. According to CVS spokesman Mike DeAngelis, retail locations continue to offer either the Moderna Inc (NASDAQ: MRNA) or Pfizer Inc (NYSE: PFE) - BioNTech SE (NASDAQ: BNTX) vaccine.

CVS Health Stops Administration Of JNJ COVID-19 Shot In Several Locations: CNBC

CVS Health has stopped offering J&J's single-dose Covid-19 in its pharmacies but will continue to make the shots available at certain MinuteClinic locations.

CVS Health stops offering J&J Covid vaccine at its pharmacies, available at select MinuteClinics

On Wednesday morning, CVS Health Corp (NYSE:CVS) shares edged 1.2% lower despite posting better than expected Q2 results. The company announced its fiscal second-quarter earnings and revenue, beating analyst expectations.

CVS Health pulls back despite posting upbeat Q2 results: could it be an opportunity to buy?

The drugstore chain and health insurer is trying to figure out what the delta coronavirus variant may mean for its business.

CVS Health says the peak of Covid vaccinations has already happened

Walgreens

COVID-19 vaccinations and tests are boosting business at CVS and Walgreens as consumers clamor for jabs and swabs amid rising infection rates.

CVS, Walgreens results get a boost from vaccinations and COVID-19 tests

CVS Health Corp. (CVS) CEO Karen Lynch on Q2 2021 Results - Earnings Call Transcript

CVS Health (CVS) Q2 adjusted EPS drops year over year on escalating costs and expenses which are putting pressure on margins.

CVS Health (CVS) Q2 Earnings Beat Estimates, EPS View Up

CVS will raise its minimum wage for hourly workers to $15 by next summer, becoming the latest large US chain to pledge a $15 starting rate as companies compete for workers in a tight labor market.

CVS will raise its minimum wage to $15 an hour

Starting July 2022, CVS Health employees will make a minimum wage of $15 per hour, a standard met by competitors Amazon, Costco, and Target.

CVS just stepped up its labor competition with Walgreens by raising its minimum wage to $15 per hour

As retailers across the U.S. continue their struggle to find enough employees, CVS Health is raising its hourly minimum wage and removing education requirements for recruitment of employees, a move that executives hope allows the company to bolster its ranks and continue growth. Incremental increases to hourly rates will start this month, the company said, […]

CVS Lifts Employees' Hourly Pay To Combat Labor Shortage

CVS Health will hike its minimum wage for employees to $15 per hour starting in July 2022, with incremental increases set to begin this month.

CVS boosts wages as profits rise on COVID-19 vaccinations, tests

CVS Health (CVS) delivered earnings and revenue surprises of 16.91% and 3.34%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

CVS Health (CVS) Q2 Earnings and Revenues Top Estimates

CVS Health Corp. and its Aetna health insurance business announced Wednesday that it will enter the Affordable Care Act individual insurance market place in these five states next year: Florida, Missouri, Nevada, North Carolina and Texas. Starting Jan. 1, 2022, the plans will feature no-cost or low-cost visits to CVS's MinuteClinics, access to a Care Concierge at CVS HealthHUB locations and 90-day refills delivered to their door for free.

Aetna, CVS to enter Affordable Care Act marketplace in these 5 states

CVS Health will raise the minimum wage of its employees to $15 an hour effective in July 2022 as the drugstore chain's business rebounds to pre-pandemic levels.

News for CVS Health Stock (CVS)